Clinical evaluation of cefluprenam for treatment of respiratory infections

• Shimokata Kaoru

  First Department of Internal Medicine, Nagoya University School of Medicine

• Ichiyama Satoshi

  First Department of Internal Medicine, Nagoya University School of Medicine

• Saka Hideo

  First Department of Internal Medicine, Nagoya University School of Medicine

• Yamamoto Masashi

  Depertment of Internal Medicine Nagoya Ekisaikai Hospital

• Nagatake Masaaki

  Depertment of Internal Medicine Nagoya Ekisaikai Hospital

• Yagi Tetsuya

  Depertment of Internal Medicine Nagoya Ekisaikai Hospital

• Murate Takanao

  Depertment of Respiratory Disease, Meitetsu Hospital

• Imaizumi Kazuyoshi

  Depertment of Respiratory Disease, Meitetsu Hospital

• Takagi Eishi

  Department of Internal Medicine, Anjou Kousei Hospital

• Yurikusa Naoko

  Department of Internal Medicine, Anjou Kousei Hospital

Bibliographic Information

Other Title

• 呼吸器感染症に対するcefluprenamの臨床的有用性の検討

Abstract

Clinical efficacy and safety of cefluprenam (CFLP) were evaluated in 11 patients with respiratory infections. CFLP were administered intravenously 0.5g or 1.0g twice daily.The duration of treatment ranged from 4 to 17 days.Clinical efficacy was excellent in 4, good in 6 and poor in one patient.Skin rash was observed in 1 patient, and abnormal laboratory findings were observed in 2 patients.The results suggest that CFLP is useful for treatment of respiratory infections.

Journal

• Japanese Journal of Chemotherapy

  Japanese Journal of Chemotherapy 43 (Supplement4), 298-301, 1995

  Japanese Society of Chemotherapy

Keywords

• cefluprenam

Details

• CRID: 1390282681262897024
• NII Article ID: 10005468170
• NII Book ID: AN10472127
• DOI: 10.11250/chemotherapy1995.43.supplement4_298
• ISSN: 18845886
• ISSN: 13407007
• Web Site: https://search.jamas.or.jp/link/ui/1996107469
• Text Lang: ja
• Data Source:
  • JaLC
  • CiNii Articles
• Abstract License Flag: Disallowed